LI-COR INC
LI-COR INC (United States) holds 1 active US FDA Type II Drug Master File and 2 inactive. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “LI-COR INC: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/li-cor-inc
Overview
LI-COR INC is an active pharmaceutical ingredient (API) supplier with 1 active FDA Type II Drug Master File, covering IRDYE 700DX CARBOXYLATE (DRUG SUBSTANCE INTERMEDIATE).
API / Drug Master Files
LI-COR INC holds 1 active (3 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.
- IRDYE 700DX CARBOXYLATE (DRUG SUBSTANCE INTERMEDIATE)Active2015-02-02
- IRDYE 800CW CARBOXYLATEInactive2014-09-25
- IRDYE 800CW NHS ESTER (DRUG SUBSTANCE INTERMEDIATE)Inactive2011-07-19
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to LI-COR INC in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.
Is this LI-COR INC?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.